Impact of the “Diabetes Interactive Diary” Telemedicine System on Metabolic Control, Risk of Hypoglycemia, and Quality of Life: A Randomized Clinical Trial in Type 1 Diabetes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Telemedicine systems based on mobile phones represent new promising educational tools. The "Diabetes Interactive Diary" (DID) is a carbohydrate/bolus calculator promoting the patient-physician communication via short message service. This study aimed to compare the efficacy of the DID versus usual care on metabolic control, hypoglycemia, and quality of life. PATIENTS AND METHODS: Patients with type 1 diabetes on a basal:bolus regimen with insulin glargine and insulin glulisine, not previously educated on carbohydrate (CHO) counting, were randomized to DID (Group A; n=63) or traditional education (Group B; n=64). Generalized hierarchical linear regression models for repeated measures were applied to compare changes between groups. Incidence of hypoglycemia was compared using Poisson regression models. RESULTS: Of 127 patients (age, 36.9±10.5 years; diabetes duration, 16.3±9.3 years), 15 (11.8%) dropped out. After 6 months, hemoglobin A1c (HbA1c) levels decreased by -0.49±0.11 in Group A and -0.48±0.11 in Group B (P=0.73). Group A showed a 86% lower risk of grade 2 hypoglycemia than Group B. Compared with usual care, DID improved the "perceived frequency of hyperglycemic episodes" scale of the Diabetes Treatment Satisfaction Questionnaire and the "social relations" and the "fear of hypoglycemia" dimensions of the Diabetes Specific Quality of Life Scale. Results obtained with DID markedly differ among patients and centers. CONCLUSIONS: DID is no more effective than traditional CHO counting education in reducing HbA1c levels. DID reduces the risk of moderate/severe hypoglycemia and improves quality of life. A better understanding of patients' and healthcare professionals' attitudes associated with an effective care supported by technology is essential to avoid waste of resources.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.148 · Cited by 1,165
Systematic review of studies of patient satisfaction with telemedicine
Mair, F. (2000) · BMJ · doi:10.1136/bmj.320.7248.1517 · Cited by 734
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559
Liang, X., Wang, Q., Yang, X., Cao, J., Chen, J., Mo, X., Huang, J., Wang, L., & Gu, D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03180.x · Cited by 515 · cited 2×
“In fact, data on efficacy and safety of technology in diabetes are increasing, 16–18 and new modalities of communication (SMS, e-mail, telephone calls, and other devices) are daily applied by clinicians as surrogates for educational activities to support patients, to reduce the time devoted to…”
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S. (2012) · Diabetes Care · doi:10.2337/dc11-1579 · Cited by 265
Rose, M., Fliege, H., Hildebrandt, M., Schirop, T., & Klapp, B. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.35 · Cited by 245 · cited 1×
“Furthermore, quality of life is widely recognized as an important correlate of adherence to treatment and favorable diabetes outcomes.(37,38) It is thus plausible that the positive impact of DID on several dimensions of quality of life could translate in the long run into better clinical results.”
Farmer, A., Gibson, O. J., Tarassenko, L., & Neil, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01627.x · Cited by 211
Carbohydrate issues: type and amount
Wheeler, M. L., & Pi-Sunyer, F. X. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.01.024 · Cited by 105
Rossi, M. C. E., Nicolucci, A., Pellegrini, F., Bruttomesso, D., Bartolo, P. D., Marelli, G., Dal Pos, M., Galetta, M., Horwitz, D., & Vespasiani, G. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0020 · Cited by 69 · cited 1×
“21 First, its feasibility, acceptability, and safety were documented in a preliminary, pilot study, 20 which involved four diabetes clinics and 50 patients with type 1 diabetes mellitus (T1DM).”
Self-citation
Research works printed but not linked: 33
- 10.2337/dc08-S061 · DOI
- American Diabetes Association:, 2003, Diabetes Care, 26, S143, 10.2337/diacare.26.2007.S143 · doi:10.2337/diacare.26.2007.s143
- 10.2337/dc05-2494 · DOI · Paper page
- 10.1111/j.1464-5491.2012.03727.x · DOI
- Campbell RK, 2012, Am J Manag Care, 18, S55
- 10.1016/S0002-8223(98)00206-5 · DOI · Paper page
- 10.1136/bmj.325.7367.746 · DOI · Paper page
- Chiesa G, 2005, Acta Biomed, 76, 44
- 10.2337/diacare.26.5.1626 · DOI · Paper page
- 10.1111/j.1464-5491.2011.03265.x · doi:10.1111/j.1464-5491.2011.03265.x
- 10.17925/EE.2010.06.00.39 · DOI
- 10.2337/dc09-1327 · DOI · Paper page
- Bradley C, 1994, Handbook of Psychology and Diabetes, 111
- Nicolucci A, 2004, Diabetes Nutr Metab, 17, 235
- 10.1097/00005650-199206000-00002 · DOI · Paper page
- 10.2337/diab.19.9.644 · DOI · Paper page
- 10.1001/jama.295.14.1681 · DOI · Paper page
- 10.1046/j.1464-5491.2002.00801.x · DOI · Paper page
- 10.2337/diacare.21.5.757 · DOI · Paper page
- Bott U, 1998, Diabetologia, 41, A74
- Ware JE, 1996, Quality of Life and Pharmacoecoeconomics, 681
- 10.1111/j.1464-5491.2007.02346.x · DOI · Paper page
- 10.1177/193229681100500118 · DOI · Paper page
- 10.2337/dc06-0383 · DOI · Paper page
- 10.1016/S0168-8227(98)00132-6 · DOI
- 10.1093/acprof:oso/9780195152968.001.0001 · DOI · Paper page
- 10.1016/j.numecd.2007.12.005 · DOI
- 10.1186/1477-7525-8-67 · DOI · Paper page
- 10.1111/j.1742-1241.2009.02332.x · DOI · Paper page
- 10.12968/bjcn.2011.16.5.246 · DOI
- 10.2337/diacare.20.11.1655 · DOI · Paper page
- 10.2337/dc06-1085 · DOI · Paper page
- 10.1111/j.1464-5491.2011.03253.x · DOI · Paper page
Cited by
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411
Shan, R., Sarkar, S., & Martin, S. S. (2019) · Diabetologia · doi:10.1007/s00125-019-4864-7 · Cited by 339
Faruque, L. I., Wiebe, N., Ehteshami-Afshar, A., Liu, Y., Dianati-Maleki, N., Hemmelgarn, B. R., Manns, B. J., & Tonelli, M. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.150885 · Cited by 281
Bonoto, B. C., de Araújo, V. E., Godói, I. P., de Lemos, L. L. P., Godman, B., Bennie, M., Diniz, L. M., & Junior, A. A. G. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6309 · Cited by 294
“In 6 studies, 75% or more of the participants had, at least, completed high school [32,33,35,42-44] and 60% of sample in the intervention group were men [37-40,42].”
InfluentialWu, Y., Yao, X., Vespasiani, G., Nicolucci, A., Dong, Y., Kwong, J., Li, L., Sun, X., Tian, H., & Li, S. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.6522 · Cited by 283
“Despite the above-mentioned issues, clinical decision making can be found in diabetes apps both in trials [44-46] and in app stores [23,28].”
InfluentialSelf-citation
Metadata
- Authors
- Rossi, M. C., Nicolucci, A., Lucisano, G., Pellegrini, F., Di Bartolo, P., Miselli, V., Anichini, R., & Vespasiani, O. B. O. T. D. S.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2013-08
- Volume
- 15
- Issue
- 8
- Pages
- 670-679
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2071575890
- Cited by
- 103
- References
- 9
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of the “Diabetes Interactive Diary” Telemedicine System on Metabolic Control, Risk of Hypoglycemia, and Quality of Life: A Randomized Clinical Trial in Type 1 Diabetes. https://app.cochat.ai/papers/10.1089/dia.2013.0021
- The paper
- Rossi, M. C., Nicolucci, A., Lucisano, G., Pellegrini, F., Di Bartolo, P., Miselli, V., Anichini, R., & Vespasiani, O. B. O. T. D. S. (2013). Impact of the “Diabetes Interactive Diary” Telemedicine System on Metabolic Control, Risk of Hypoglycemia, and Quality of Life: A Randomized Clinical Trial in Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2013.0021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.